Go offline with the Player FM app!
Hema Now: Episode 21 The Global Perspectives on Myeloma
Manage episode 493870676 series 3412919
In this episode, Jonathan Sackier welcomes Claudio Cerchione, haematologist and researcher at the Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. From his early interest in plasma cell disorders, Cerchione shares key insights into the evolution of multiple myeloma (MM) research, the rising role of minimal residual disease (MRD), and promising developments in monoclonal antibodies and CAR-T therapy. He also reflects on standout moments from recent European Hematology Association (EHA) Congress and American Society of Clinical Oncology (ASCO) Annual Meeting, and shares his hopes for the future of haematology.
Timestamps:
2:14: Memorable career experiences for Claudio
4:20 Biggest breakthrough in MM
5:10 Interest in plasma cell disorders
6:30 A surprising fact about multiple myeloma
7:40 Claudio’s top choice for a dinner party guest
10:30 The importance of MRD in haematology
13:00 Monoclonal antibodies and CAR-T therapies
19:00 Current challenges
22:22 Claudio’s key EHA and ASCO takeaways
28:30 Claudio’s three magic wishes
199 episodes
Manage episode 493870676 series 3412919
In this episode, Jonathan Sackier welcomes Claudio Cerchione, haematologist and researcher at the Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. From his early interest in plasma cell disorders, Cerchione shares key insights into the evolution of multiple myeloma (MM) research, the rising role of minimal residual disease (MRD), and promising developments in monoclonal antibodies and CAR-T therapy. He also reflects on standout moments from recent European Hematology Association (EHA) Congress and American Society of Clinical Oncology (ASCO) Annual Meeting, and shares his hopes for the future of haematology.
Timestamps:
2:14: Memorable career experiences for Claudio
4:20 Biggest breakthrough in MM
5:10 Interest in plasma cell disorders
6:30 A surprising fact about multiple myeloma
7:40 Claudio’s top choice for a dinner party guest
10:30 The importance of MRD in haematology
13:00 Monoclonal antibodies and CAR-T therapies
19:00 Current challenges
22:22 Claudio’s key EHA and ASCO takeaways
28:30 Claudio’s three magic wishes
199 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.